Northern Trust’s ACELYRIN SLRN Stock Holding History

Northern Trust’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-598,151	Closed	-$1.48M	–	4485
2025 Q1	$1.48M	Sell	598,151 -31,900	-5%	-$75.8K	﹤0.01%	3083
2024 Q4	$1.98M	Buy	630,051 +23,130	+4%	+$112K	﹤0.01%	3032
2024 Q3	$2.99M	Buy	606,921 +103,469	+21%	+$534K	﹤0.01%	2750
2024 Q2	$2.22M	Sell	503,452 -15,632	-3%	-$73.3K	﹤0.01%	2846
2024 Q1	$3.5M	Buy	519,084 +228,629	+79%	+$1.74M	﹤0.01%	2687
2023 Q4	$2.17M	Buy	290,455 +10,480	+4%	+$89.4K	﹤0.01%	2960
2023 Q3	$2.85M	Buy	279,975 +221,850	+382%	+$4.71M	﹤0.01%	2744
2023 Q2	$1.21M	Buy	+58,125	New	+$1.19M	﹤0.01%	3282

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northern Trust's SLRN Position: Q2 2025 in Review

Northern Trust sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 598,151 shares — an estimated $1.48M sold.

Northern Trust first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $3.5M in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Northern Trust reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Northern Trust sold 598,151 ACELYRIN shares in Q2 2025, an estimated $1.48M.
Northern Trust first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
Northern Trust's ACELYRIN position peaked at $3.5M in Q1 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.